Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BCL3 |
| Upstream (Parents) |
|---|
| (<<) POU6F2 → BCL3 |
| (<<) SHOX → BCL3 |
| (<<) TSC22D2 → BCL3 |
| (<<) RARA → BCL3 |
| (<<) ZNF192 → BCL3 |
| (<<) SPI1 → BCL3 |
| (<<) EPAS1 → BCL3 |
| (<<) TCF15 → BCL3 |
| (<<) TCF7 → BCL3 |
| (<<) BATF3 → BCL3 |
| (<<) HOXB2 → BCL3 |
| Downstream (Children) |
|---|
| BCL3 → IRF4 (>>) |
| BCL3 → MYT1L (>>) |
| BCL3 → PGR (>>) |
| BCL3 → NR5A1 (>>) |
| BCL3 → TBX4 (>>) |
| BCL3 → SIX5 (>>) |
| BCL3 → TAL1 (>>) |
| BCL3 → ATF6B (>>) |
| BCL3 → LHX3 (>>) |
| BCL3 → CREB5 (>>) |
